Mallinckrodt Execs See Securities Fraud Claims Trimmed
By Emilie Ruscoe · July 1, 2025, 10:12 PM EDT
Mallinckrodt Pharmaceuticals executives must face investors' claims alleging they concealed signs of the company's impending 2023 bankruptcy and share cancellations, but a New Jersey federal judge pared down allegations against two...
To view the full article, register now.